期刊文献+

HPLC测定左乙拉西坦中的有关物质 被引量:5

Determination of related substances in Levetiracetam by HPLC
原文传递
导出
摘要 目的采用HPLC法测定左乙拉西坦中的有关物质。方法采用Diamonsil C18色谱柱(250 mm×4.6 mm,5μm),流动相为0.01 mol.L-1磷酸氢二钠-乙腈-三乙胺(92∶8∶0.1,磷酸调pH6),流速1.0 mL.min-1,检测波长205 nm。结果吡咯酮酸杂质相对于主成分左乙拉西坦的tR约为0.51,校正因子为1.15,检测限为2 ng,4批样品中吡咯酮酸的含量为0.027%~0.029%,其他有关物质为0.019%~0.108%。结论所建方法准确、简便、快速,适用于左乙拉西坦中微量杂质的控制。 OBJECTIVE To establish an RP-HPLC method for determination of the related substances in Levetiracetam.METHODS The analytical column was Diamonsil C18 column(250 mm×4.6 mm,5 μm).The mobile phase consisted of phosphate buffer(0.01 mol·L-1 NaH2PO4)-acetonitrile-triethylamine(92:8:0.1,adjusting pH to 6 with phosphoric acid).The flow rate was 1.0 mL·min-1 and the detective wavelength was 205 nm.RESULTS The relative retention time between(S)-α-Ethyl-2-oxo-1-pyrrolidineacetic and Levetiracetam was about 0.51 with the correction factor of 1.15,the detection limit of Levetiracetam was 2 ng.in four batches of samples,the contents of(S)-α-ethyl-2-oxo-1-pyrrolidineacetic and related substances were 0.027%-0.029% and 0.019%-0.108%,respectively.CONCLUSION The method is accurate,simple,sensitive and suitable for quality control of trace impurities in Levetiracetam.
出处 《华西药学杂志》 CAS CSCD 北大核心 2011年第4期382-383,共2页 West China Journal of Pharmaceutical Sciences
关键词 左乙拉西坦 有关物质 校正因子 高效液相色谱法 Levetiracetam Related substances Corrected factor HPLC
  • 相关文献

参考文献3

  • 1王学禹,李明霞.左乙拉西坦在癫痫治疗中的应用进展[J].山东医药,2008,48(11):110-111. 被引量:27
  • 2中华人民共和国国家药典委员会.中国药典[S].二部.北京:中国医药科技出版社,2010:1124.
  • 3附录减.国家食品药品监督管理局药品审评中心.化学药物研究技术指导原则[S].2005.

二级参考文献6

  • 1Carunchio I, Piert M, Ciotti MT, et al. Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptlc drug levetiracetam [ J ]. Epilepsia,2007,48 ( 4 ) : 654.662.
  • 2Brandt C, Glien M, Gastens AM, et al. Prophylactic treatment with levetlracetam after status epilepticus : Lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats [ J ]. Neuropharmacology, 2007,53 ( 2 ) : 207 -221.
  • 3Shorvon SD, Lowenthal A, Janz D, et al. Multicenter double-blind, randomized,placebo-controlled trial of levetiraceam as add-on therapy in patients with refractory partial seizure.s[ J]. Epilepsia,2000,41 (9) :1179-1186.
  • 4Striano P, Goppola A, Pezzella M, et al. An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy [ J ]. Neurology, 2007,69 ( 3 ) :250-254.
  • 5Mula M, Sander JW. Suicidal ideation in epilepsy and levetiracetam therapy[ J]. Epilepsy Behav,2007,11 ( 1 ) :130-132.
  • 6Ondo WC,Jimenz JE,Vuong KD,et al. An open-label pilot study of levetiracetam for essential tremor[ J]. Clin Neuropharmacol,2004,27 (6) :274-277.

共引文献32

同被引文献36

  • 1崔蕊,李文莉,崔超,张丹.HPLC测定左乙拉西坦中的右旋异构体[J].华西药学杂志,2010,25(5):593-594. 被引量:2
  • 2肖拥军,罗湘冀.高效液相色谱法测定左乙拉西坦片的含量[J].广东药学院学报,2005,21(6):687-688. 被引量:7
  • 3刘跃金,陈道鹏,梁良,刘丹,孙志祥.左乙拉西坦及其衍生物的合成[J].中国新药杂志,2007,16(11):860-864. 被引量:9
  • 4吴新民,许幸,王俊科,王鲲鹏,薛张纲,缪长虹,邓小明,艾登斌,于浩.静脉注射右美托咪啶辅助全身麻醉的有效性和安全性[J].中华麻醉学杂志,2007,27(9):773-776. 被引量:242
  • 5Saikfishna K,Bikshapathi, DVRN,Kumar UA,et al. New RP- HPLC method for the determination of levetiracetam in bulk and prepared tablets [ J ]. Asian Journal of Biochemical and Pharmaceutical Re- search, 2011, 1(3) : 294-301.
  • 6Al Masud A,Arefeen MS, Islam MK, et al. Development and valida- tion of a RP- HPLC method for the estimation of levetiracetam in bulk and pharmaceutical formulation [ J ]. Journal of Chemical and Phar- maceutical Research,2011, 3(1 ): 324-329.
  • 7US Pharmacopeia Convention. USP36/NF31 [ S ]. Bahimore, MD: United Book Press,2013:4084-4086.
  • 8Council of Europe. EPS. 0 [ S ]. Beck Nordlingen : Druckerei C. H,2013:2352 - 2353.
  • 9British Pharmacopoeia Commission. Bit2014 [ S ]. London: The stationery Office,2010:2313 - 2316.
  • 10CARUNCHIO I,PIERI M,CIOTTI MT,et al.Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiraeetam[J].Epilepsia,2007,48(4):654.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部